Dana Investment Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,757
| Closed | -$239K | – | 587 |
|
|
2026
Q1 | $239K | Buy |
2,757
+49
| +2% | +$4.69K | 0.01% | 531 |
|
|
2025
Q4 | $260K | Buy |
2,708
+275
| +11% | +$26.7K | 0.01% | 527 |
|
|
2025
Q3 | $232K | Buy |
2,433
+77
| +3% | +$7.08K | 0.01% | 532 |
|
|
2025
Q2 | $205K | Buy |
2,356
+109
| +5% | +$9.24K | 0.01% | 532 |
|
|
2025
Q1 | $202K | Sell |
2,247
-650
| -22% | -$58.2K | 0.01% | 534 |
|
|
2024
Q4 | $231K | Sell |
2,897
-651
| -18% | -$56.4K | 0.01% | 520 |
|
|
2024
Q3 | $319K | Sell |
3,548
-17,667
| -83% | -$1.49M | 0.01% | 489 |
|
|
2024
Q2 | $1.67M | Sell |
21,215
-336
| -2% | -$27.5K | 0.06% | 316 |
|
|
2024
Q1 | $1.88M | Buy |
21,551
+1,333
| +7% | +$114K | 0.06% | 296 |
|
|
2023
Q4 | $1.67M | Sell |
20,218
-1,825
| -8% | -$139K | 0.08% | 174 |
|
|
2023
Q3 | $1.73M | Buy |
22,043
+6,597
| +43% | +$552K | 0.09% | 156 |
|
|
2023
Q2 | $1.36M | Buy |
15,446
+1,226
| +9% | +$106K | 0.07% | 206 |
|
|
2023
Q1 | $1.15M | Buy |
14,220
+337
| +2% | +$27.5K | 0.06% | 218 |
|
|
2022
Q4 | $1.08M | Buy |
13,883
+306
| +2% | +$24.8K | 0.06% | 216 |
|
|
2022
Q3 | $1.1M | Sell |
13,577
-1,599
| -11% | -$144K | 0.06% | 204 |
|
|
2022
Q2 | $1.36M | Buy |
15,176
+6,094
| +67% | +$617K | 0.07% | 186 |
|
|
2022
Q1 | $1.01M | Buy |
9,082
+7,032
| +343% | +$743K | 0.05% | 214 |
|
|
2021
Q4 | $212K | Sell |
2,050
-566
| -22% | -$65.5K | 0.01% | 319 |
|
|
2021
Q3 | $328K | Buy |
2,616
+166
| +7% | +$21.5K | 0.01% | 279 |
|
|
2021
Q2 | $304K | Sell |
2,450
-114
| -4% | -$14.3K | 0.01% | 283 |
|
|
2021
Q1 | $303K | Buy |
+2,564
| New | +$301K | 0.01% | 286 |
|
|
2020
Q3 | – | Sell |
-41,499
| Closed | -$3.81M | – | 292 |
|
|
2020
Q2 | $3.81M | Sell |
41,499
-491
| -1% | -$47.1K | 0.21% | 85 |
|
|
2020
Q1 | $3.79M | Buy |
41,990
+6,161
| +17% | +$655K | 0.23% | 77 |
|
|
2019
Q4 | $4.07M | Sell |
35,829
-7,087
| -17% | -$778K | 0.2% | 81 |
|
|
2019
Q3 | $4.66M | Buy |
42,916
+268
| +0.6% | +$28K | 0.24% | 80 |
|
|
2019
Q2 | $4.15M | Buy |
42,648
+1,287
| +3% | +$118K | 0.21% | 87 |
|
|
2019
Q1 | $3.77M | Buy |
+41,361
| New | +$3.7M | 0.18% | 96 |
|
|
2016
Q1 | – | Sell |
-219
| Closed | -$219 | – | 290 |
|
|
2015
Q4 | $219 | Sell |
219
-20,119
| -99% | -$1.51M | 0.01% | 268 |
|
|
2015
Q3 | $1.36M | Buy |
20,338
+6,338
| +45% | +$467K | 0.06% | 163 |
|
|
2015
Q2 | $1.04M | Buy |
14,000
+6,390
| +84% | +$488K | 0.05% | 201 |
|
|
2015
Q1 | $594K | Buy |
+7,610
| New | +$577K | 0.03% | 210 |
|
Other funds holding MDT
Dana Investment Advisors's MDT Position: Q2 2026 in Review
Dana Investment Advisors sold out of Medtronic (MDT) in Q2 2026, closing a stake of 2,757 shares — an estimated $239K sold.
Dana Investment Advisors first reported a position in MDT in Q1 2015 and held it in 31 quarters. The position peaked at $4.66M in Q3 2019. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Dana Investment Advisors reported no remaining Medtronic position as of Q2 2026 after selling out during the quarter.
- Dana Investment Advisors sold 2,757 Medtronic shares in Q2 2026, an estimated $239K.
- Dana Investment Advisors first reported a position in Medtronic in Q1 2015 and held it in 31 quarters.
- Dana Investment Advisors's Medtronic position peaked at $4.66M in Q3 2019.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.